Hepatic Apolipoprotein M Suppresses Hepatocyte Secretion of Prothrombin by Upregulating Arid5B

Makoto Kurano1, Baasanjav Uranbileg1, Yutaka Yatomi1

  • 1Department of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, Japan.

PubMed
Abstract

Insights

Apolipoprotein M (ApoM) influences blood clotting by regulating prothrombin levels. ApoM suppresses prothrombin secretion from hepatocytes, impacting platelet counts and coagulation times.

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Biology

Background:

  • High-density lipoprotein (HDL) exhibits pleiotropic effects, including anti-thrombotic properties.
  • Apolipoprotein M (ApoM), an HDL-associated protein, carries sphingosine-1-phosphate (S1P).
  • The role of ApoM in coagulopathy remains largely unexplored.

Purpose of the Study:

  • To investigate the association between Apolipoprotein M (ApoM) and coagulopathy.
  • To elucidate the mechanisms by which ApoM affects coagulation parameters.

Main Methods:

  • Murine lipopolysaccharide-induced sepsis model to assess coagulopathy.
  • ApoM overexpression and knockout mouse models.
  • Prothrombin time and activated partial thromboplastin time assays.
  • HepG2 cell line experiments for prothrombin secretion analysis.
  • RNA sequencing to identify interacting factors.

Main Results:

  • ApoM modulated platelet counts and coagulation times in a sepsis model.
  • ApoM decreased plasma prothrombin levels while increasing hepatic and cellular prothrombin levels.
  • ApoM upregulated Arid5B expression in hepatocytes.
  • Arid5B knockdown antagonized ApoM's inhibitory effect on prothrombin secretion, independent of S1P receptors.

Conclusions:

  • Hepatic ApoM suppresses hepatocyte prothrombin secretion via Arid5B upregulation.
  • ApoM plays a significant role in regulating coagulopathy, independent of S1P signaling pathways.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
911
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
226
Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
285
Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
1.3K
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
102
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
2.3K